GAM
JNP

Gemmer Asset Management’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Gemmer Asset Management’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-6
Closed – – 1334
2015
Q4 		$0 Hold
6
– – ﹤0.01% 1320
2015
Q3 		$0 Hold
6
– – ﹤0.01% 1349
2015
Q2 		$0 Buy
+6
New +$45 ﹤0.01% 1386

Other funds holding JNP

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Gemmer Asset Management's JNP Position: Q1 2016 in Review

Gemmer Asset Management sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q1 2016, closing a stake of 6 shares.

Gemmer Asset Management first reported a position in JNP in Q2 2015 and held it in 3 quarters. The position peaked at $0 in Q4 2015. 50 funds tracked by Wall St. Rank hold JNP as of Q1 2016.

  • Gemmer Asset Management reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • Gemmer Asset Management sold 6 Juniper Pharmaceuticals, Inc. Common Stock shares in Q1 2016.
  • Gemmer Asset Management first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q2 2015 and held it in 3 quarters.
  • Gemmer Asset Management's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $0 in Q4 2015.
  • 50 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q1 2016.

Based on Gemmer Asset Management's 13F filing for Q1 2016, filed 15 Apr 2016.